Guidance

Merger remedies

Guidance on merger remedies in Phase 1 and Phase 2 investigations.

Documents

Merger remedies guidance

Details

This guidance is intended for merger parties and their advisers. It explains the CMA’s approach to the selection, design and implementation of remedies for in phase 1 and phase 2 merger investigations.

We’re consulting on proposed changes to this guidance.

Updates to this page

Published 1 November 2008
Last updated 13 December 2018 show all updates
  1. The merger remedies guidance has been updated following consultation.

  2. First published.

Sign up for emails or print this page